- Sun Pharmaceutical Industries Limited announced its financial results for Q1 of FY 2025-26.
- Gross sales reached Rs. 137,861 million, reflecting a growth of 10.1% year-on-year.
Join the vibrant privacy-ensured Dzambhala community on
Want to give feedback on this story? Write to us at [email protected]